For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220628:nRSb4853Qa&default-theme=true
RNS Number : 4853Q IQE PLC 28 June 2022
IQE plc
Cardiff, UK
28 June 2022
Results of Annual General Meeting
IQE plc (AIM: IQE, "IQE" or the "Group"), the leading supplier of compound
semiconductor wafer products and advanced material solutions to the global
semiconductor industry, is pleased to announce that at its 2022 Annual General
Meeting, held today in London, UK, all resolutions were duly passed.
Votes were cast as shown below:
Ordinary Resolution 1: Receipt of Directors' Report & Financial Statements
For: 437,855,113 - 99.99%
Against: 32,774 - 0.01%
Withheld: 42,447
Ordinary Resolution 2: Approval of the Directors' Annual Report on
Remuneration
For: 433,500,728 - 99.00%
Against: 4,376,693 - 1.00%
Withheld: 52,913
Ordinary Resolution 3: To re-elect Phil Smith
For: 436,091,562 - 99.60%
Against: 1,736,260 - 0.40%
Withheld: 102,512
Ordinary Resolution 4: To re-elect Americo Lemos
For: 437,679,640 - 99.97%
Against: 148,382 - 0.03%
Withheld: 102,312
Ordinary Resolution 5: To re-elect Tim Pullen
For: 437,268,044 - 99.87%
Against: 555,320 - 0.13%
Withheld: 106,970
Ordinary Resolution 6: To re-elect Carol Chesney
For: 436,120,667 - 99.61%
Against: 1,700,879 - 0.39%
Withheld: 108,788
Ordinary Resolution 7: To re-elect Victoria Hull
For: 437,493,735 - 99.92%
Against: 329,989 - 0.08%
Withheld: 106,610
Ordinary Resolution 8: To re-elect Andrew Nelson
For: 436,839,051 - 99.78%
Against: 984,673 - 0.22%
Withheld: 106,610
Ordinary Resolution 9: To re-elect Derek Jones
For: 436,234,583 - 99.64%
Against: 1,560,337 - 0.36%
Withheld: 135,414
Ordinary Resolution 10: Reappointment of auditor
For: 437,474,069 - 99.93%
Against: 314,665 - 0.07%
Withheld: 141,600
Ordinary Resolution 11: Directors' authority to allot shares
For: 437,187,043 - 99.86%
Against: 631,410 - 0.14%
Withheld: 111,881
Special Resolution 12: Disapplication of pre-emption rights
For: 430,661,706 - 98.40%
Against: 7,001,220 - 1.60%
Withheld: 267,408
Special Resolution 13: Additional authority for disapplication of
pre-emption rights
For: 430,661,424 - 98.40%
Against: 6,989,625 - 1.60%
Withheld: 279,285
Contacts:
IQE plc
+44 (0) 29 2083 9400
Americo Lemos
Tim Pullen
Amy Barlow
Peel Hunt LLP (Nomad and Joint Broker)
+44 (0) 20 7418 8900
Edward Knight
Paul Gillam
James Smith
Citigroup Global Markets Limited (Joint Broker)
+44 (0) 20 7986 4000
Christopher Wren
Peter Catterall
Headland Consultancy (Financial PR)
+ 44 (0) 20 38054822
Andy Rivett-Carnac: +44 (0) 7968 997 365
Antonia Pollock: +44 (0) 7789 954 356
embedded PR (Non-Financial PR)
Europe: Anja-Maria Hastenrath
Phone: +49 89 / 64913634-1
E-mail: ah@embedded-pr.de (mailto:ah@embedded-pr.de)
United States: Cynthia Hoye
Phone: +1 408-858-2602
E-mail: ch@embedded-pr.com (mailto:ch@embedded-pr.com)
ABOUT IQE
http://iqep.com
(https://www.globenewswire.com/Tracker?data=yZf7NKp1JKLALUCxlBuC8wkLnLAqoe5-kjjIlkMIDci9q9W0x_02bwZV-eorSbpLXZxy4zi3xHh-O4FM8nWjeg==)
IQE is the leading global supplier of advanced compound semiconductor wafers
and materials solutions that enable a diverse range of applications across:
· handset devices
· global telecoms infrastructure
· connected devices
· 3D Sensing
As a scaled global epitaxy wafer manufacturer, IQE is uniquely positioned in
this market which has high barriers to entry. IQE supplies the whole market
and is agnostic to the winners and losers at chip and OEM level. By leveraging
the Group's intellectual property portfolio including know-how and patents, it
produces epitaxy wafers of superior quality, yield and unit economics.
IQE is headquartered in Cardiff UK, with c. 685 employees across nine
manufacturing locations in the UK, US, Taiwan and Singapore, and is listed on
the AIM Stock Exchange in London.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END RAGEAFKPAFAAEFA